{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:36:52Z","timestamp":1778315812156,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.atherosclerosis.2009.04.024","type":"journal-article","created":{"date-parts":[[2009,4,25]],"date-time":"2009-04-25T05:06:11Z","timestamp":1240635971000},"page":"277-283","source":"Crossref","is-referenced-by-count":31,"title":["Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis"],"prefix":"10.1016","volume":"207","author":[{"given":"C.T.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kamineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Palmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.ATV.0000013904.40673.CC","article-title":"Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects","volume":"22","author":"Kato","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib2","first-page":"291","article-title":"Tissue factor pathway inhibitor expression in atherosclerosis","volume":"77","author":"Drew","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.CIR.98.11.1051","article-title":"Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity","volume":"98","author":"Caplice","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.ATV.20.5.1362","article-title":"Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels","volume":"20","author":"Crawley","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib5","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/01.CIR.92.10.3041","article-title":"Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model","volume":"92","author":"Jang","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0037-1615237","article-title":"Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta","volume":"80","author":"Asada","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0008-6363(02)00595-3","article-title":"Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries","volume":"56","author":"Yin","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib8","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"Westrick","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.ATV.16.6.802","article-title":"Measurement of the free form of TFPI antigen in hyperlipidemia. Relationship between free and endothelial cell-associated forms of TFPI","volume":"16","author":"Kokawa","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1055\/s-0037-1615954","article-title":"Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers","volume":"85","author":"Morange","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib11","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.99.22.2908","article-title":"Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina","volume":"99","author":"Soejima","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib12","first-page":"366","article-title":"TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications","volume":"24","author":"Novo","year":"2005","journal-title":"Int Angiol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9150(99)00444-X","article-title":"Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls","volume":"152","author":"Blann","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1538-7836.2007.02372.x","article-title":"Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study","volume":"5","author":"Morange","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0037-1615152","article-title":"Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort","volume":"80","author":"Sakkinen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.atherosclerosis.2004.05.017","article-title":"Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries","volume":"176","author":"Sakata","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiol.2341040439","article-title":"Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"234","author":"Carr","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA..107.181425","volume":"115","author":"Greenland","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.atherosclerosis.2005.08.010","article-title":"Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA)","volume":"186","author":"Sharrett","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1538-7836.2005.01237.x","article-title":"A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)","volume":"3","author":"Dahm","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1871","article-title":"Tissue factor pathway inhibitor: structure, biology and involvement in disease","volume":"208","author":"Lwaleed","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.atherosclerosis.2009.04.024_bib24","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1111\/j.1538-7836.2006.02237.x","article-title":"Plasma hemostatic factors and endothelial markers in four racial\/ethnic groups: the MESA study","volume":"4","author":"Lutsey","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009002950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T13:55:50Z","timestamp":1558274150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009002950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0021915009002950"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.04.024","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}